Insider Selling: Scholar Rock Holding Co. (NASDAQ:SRRK) Director Sells 5,400 Shares of Stock

Scholar Rock Holding Co. (NASDAQ:SRRK - Get Free Report) Director Kristina Burow sold 5,400 shares of the firm's stock in a transaction that occurred on Thursday, May 29th. The stock was sold at an average price of $29.72, for a total transaction of $160,488.00. Following the sale, the director now owns 21,071 shares in the company, valued at approximately $626,230.12. This trade represents a 20.40% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Scholar Rock Trading Up 4.0%

NASDAQ:SRRK traded up $1.18 during trading hours on Tuesday, reaching $30.94. 802,164 shares of the company were exchanged, compared to its average volume of 1,268,102. The company has a debt-to-equity ratio of 0.63, a current ratio of 3.88 and a quick ratio of 3.88. The firm has a market cap of $2.94 billion, a price-to-earnings ratio of -13.17 and a beta of 0.37. Scholar Rock Holding Co. has a 52-week low of $6.76 and a 52-week high of $46.98. The stock has a 50 day simple moving average of $30.33 and a 200 day simple moving average of $36.12.

Scholar Rock (NASDAQ:SRRK - Get Free Report) last posted its quarterly earnings results on Wednesday, May 14th. The company reported ($0.67) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by ($0.04). During the same period in the prior year, the firm earned ($0.59) EPS. As a group, analysts predict that Scholar Rock Holding Co. will post -2.42 EPS for the current year.

Hedge Funds Weigh In On Scholar Rock

Large investors have recently bought and sold shares of the stock. Global Retirement Partners LLC raised its stake in Scholar Rock by 584.7% during the fourth quarter. Global Retirement Partners LLC now owns 897 shares of the company's stock worth $39,000 after purchasing an additional 766 shares during the period. CWM LLC raised its stake in Scholar Rock by 152.8% during the first quarter. CWM LLC now owns 996 shares of the company's stock worth $32,000 after purchasing an additional 602 shares during the period. Nisa Investment Advisors LLC raised its stake in shares of Scholar Rock by 1,321.8% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,109 shares of the company's stock valued at $48,000 after acquiring an additional 1,031 shares during the period. GF Fund Management CO. LTD. purchased a new position in shares of Scholar Rock in the 4th quarter valued at $85,000. Finally, Federated Hermes Inc. purchased a new position in shares of Scholar Rock in the 1st quarter valued at $71,000. Hedge funds and other institutional investors own 91.08% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Wedbush restated an "outperform" rating and set a $50.00 target price on shares of Scholar Rock in a research report on Wednesday, May 14th. Six analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $42.67.

About Scholar Rock

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.